Bepotastine Besilate
10 NDCs across 4 manufacturers|8 Generic,2 Brand
Bepotastine Besilate is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 8, 2009, and the first generic was approved Mar 5, 2019. In 2024, Medicare Part D spent $11 million on Bepotastine Besilate across 63,000 claims for 18,000 beneficiaries.
Bepotastine Besilate is available as 10 NDCs from 4 manufacturers (8 generic, 2 brand), with NADAC prices from $8.29 to $55.94 per ML — the most expensive product costs about 6.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
8G / 2B
Manufacturers
4
competing in market
Price Spread
$8.29 – $55.94
per ML
7d Activity
avg -3.9% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch & Lomb Incorporated manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Histamine-1 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing BEPOTASTINE BESILATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BEPREVE 1.5% EYE DROPS | $55.9357 per ML | — |
BEPREVE 1.5% EYE DROPS | $53.8111 per ML | — |
BEPOTASTINE 1.5% EYE DROP | $10.4866 per ML | -6.81% |
BEPOTASTINE 1.5% EYE DROP | $10.4866 per ML | -6.81% |
BEPOTASTINE 1.5% EYE DROP | $10.4866 per ML | -6.81% |
BEPOTASTINE 1.5% EYE DROP | $10.4866 per ML | -6.81% |
BEPOTASTINE 1.5% EYE DROP | $8.2857 per ML | -0.88% |
BEPOTASTINE 1.5% EYE DROP | $8.2857 per ML | -0.88% |
BEPOTASTINE 1.5% EYE DROP | $8.2857 per ML | -0.88% |
BEPOTASTINE 1.5% EYE DROP | $8.2857 per ML | -0.88% |
Frequently Asked Questions
What is Bepotastine Besilate used to treat?
Bepotastine Besilate is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
When did Bepotastine Besilate become available as a generic?
FDA approved the first generic Bepotastine Besilate (ANDA) on Mar 5, 2019.
How much does Medicare spend on Bepotastine Besilate?
In 2024, Medicare Part D spent $11 million on Bepotastine Besilate across 63,000 claims for 18,000 beneficiaries.
How many Bepotastine Besilate products are on the market?
The Bepotastine Besilate drug market contains 10 NDCs from 4 manufacturers — 8 generic and 2 brand products.
What is the price range for Bepotastine Besilate?
NADAC reference prices for Bepotastine Besilate range from $8.2857 to $55.9357 per ML — the most expensive product costs about 6.8× the cheapest.
Is generic Bepotastine Besilate cheaper than brand?
The average generic NADAC for Bepotastine Besilate is $9.3862 per ML, versus $54.8734 for brand-labeled products — brand versions average about 5.8× the generic price.
Which manufacturers make Bepotastine Besilate?
4 manufacturers list Bepotastine Besilate in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (4), Somerset Therapeutics, LLC (2), Mylan Pharmaceuticals Inc. (2), Bausch & Lomb Americas Inc. (2).
How has the price of Bepotastine Besilate changed recently?
Over the past 7 days, 0 Bepotastine Besilate NDCs rose and 8 fell, with a market-wide average change of -3.9%.